Danone S.A. Revenue & Financials

Danone generated $29.8 billion in consolidated sales for FY2024, equivalent to approximately $29.70 billion at the average EUR/USD exchange rate of 1.085 for the year. This represented a 0.9% reported decline from FY2023's $30.1 billion but a 4.3% increase on a like-for-like basis, driven by +3.0% volume/mix growth and +1.3% price growth. The divergence between reported and like-for-like growth reflects two factors: a negative scope impact of -4.8% (predominantly from the EDP Russia exit and the Horizon Organic/Wallaby divestitures) and a negative foreign exchange impact of -2.8%, partially offset by a +1.6% hyperinflation contribution from Argentina and other high-inflation markets. The scope impact of -4.8% ($1.4 billion) was the largest drag on reported growth, reflecting strategic portfolio decisions made by de Saint-Affrique. The EDP Russia exit removed approximately $545.0 million in annual revenue, while the Horizon Organic and Wallaby divestitures removed approximately $327.0 million. These divestitures, while improving portfolio quality and margin mix, created a revenue gap that like-for-like growth could not fully offset. The foreign exchange impact of -2.8% ($842.6 million) reflected euro strength against emerging-market currencies, particularly the Argentine peso, Turkish lira, and Brazilian real. The hyperinflation contribution of +1.6% ($481.8 million) was entirely from Argentina, where IAS 29 accounting required inflation-adjusted revenue recognition. Recurring operating income reached $3.9 billion in FY2024, up 2.2% from $3.8 billion in FY2023, producing a recurring operating margin of 13.0%—an improvement of 39 basis points from 12.6% the prior year. This margin expansion was driven by operational productivity gains contributing +242 basis points, partially offset by reinvestment in advertising, promotion, and capabilities (-173 bps), overhead inflation (-18 bps), and foreign exchange effects (-12 bps). The productivity gains of +242 bps were described by management as "record levels" and reflected manufacturing efficiency improvements, procurement optimization across the 64,000-farmer dairy network, supply-chain digitization, and overhead reduction. The reinvestment of -173 bps was deliberate: de Saint-Affrique prioritized brand-building and capability development over short-term margin maximization, believing that sustained volume growth requires advertising and R&D investment. Operating income under IFRS standards was $3.7 billion, up 65.4% from $2.2 billion in FY2023, with the improvement reflecting lower non-recurring charges: $195.1 million in 2024 versus $1.6 billion in 2023. The FY2023 non-recurring charges included $769.5 million from the EDP Russia deconsolidation, $464.3 million from the US premium organic dairy sale, and $335.7 million in other restructuring costs. The FY2024 non-recurring charges of $195.1 million were primarily related to ongoing restructuring programs and acquisition-related costs, representing a significant normalization of the company's cost structure. Net income attributable to Group share surged 129.4% to $2.2 billion from $960.3 million in FY2023, yielding basic earnings per share of $3.4 and diluted EPS of $3.4—up from $1.5 in FY2023. This 130% increase reflects both the operational improvement and the absence of one-time charges that had depressed FY2023 earnings. Recurring net income, which excludes non-recurring items and is the metric management uses for guidance and dividend policy, was $2.6 billion, up 2.7% from $2.5 billion, with recurring EPS of $4 versus $3.9. The modest 2.7% growth in recurring net income—despite 4.3% like-for-like sales growth—reflects the margin reinvestment strategy and currency headwinds that affected reported profitability. The effective tax rate improved from 45.6% in FY2023 to 31.0% in FY2024, a 1,460 basis point improvement driven by three factors: the absence of one-time tax impacts related to the prior year's divestitures (which had included withholding taxes on repatriated disposal proceeds), a more favorable geographic mix of profits toward lower-tax jurisdictions (China, Singapore, Switzerland), and the recognition of deferred tax assets that had previously been reserved. The 31.0% effective rate is closer to Danone's normalized tax rate of 28-32%, suggesting that FY2024 represents a return to sustainable tax expense rather than the anomalous FY2023 rate. Cash flow from operating activities totaled $4.2 billion, up 11.3% from $3.7 billion, with working capital contributing $582.1 million positively versus $301.9 million in FY2023. The working capital improvement reflected inventory optimization (reducing yogurt and water stock levels by 8% in volume terms), receivables collection improvements (DSO reduced by 3 days), and payables management extending supplier terms by 2 days. Capital expenditure increased to $1006.1 million from $923.2 million as Danone invested in manufacturing modernization ($370.6 million), capacity expansion in North America and China ($305.2 million), and digital infrastructure ($196.2 million). Free cash flow reached $3.3 billion, up 14.0% from $2.9 billion and exceeding analyst expectations of approximately $2.7 billion by 20%. This strong cash generation funded $1.5 billion in dividends ($2.3 per share, up 2.4% from $2.3), $82.8 million in share-based compensation capital increases, and net debt reduction of approximately $436.0 million. The dividend payout ratio of 57% of recurring net income is conservative relative to European consumer staples peers (Nestlé: 65%, Unilever: 60%), reflecting management's desire to preserve balance sheet flexibility for acquisitions. Net debt stood at approximately $12.5 billion at year-end, with a net debt/EBITDA ratio of approximately 2.5x—comfortably within investment-grade parameters (S&P: BBB+, Moody's: Baa1, Fitch: A-). The company's balance sheet includes $7.2 billion in cash and short-term investments, providing liquidity coverage of approximately 2.3x annual debt service. Danone's return on invested capital (ROIC), which management has identified as a key priority, returned to double-digit territory in 2024 for the first time in several years. While the exact figure was not disclosed, management confirmed it exceeded 10% in the February 2025 earnings call, up from approximately 8-9% in FY2023. This improvement reflects both margin expansion and capital efficiency measures, including working capital optimization and disciplined capex allocation. The ROIC improvement is critical for Danone's valuation: the company's price-to-earnings ratio of approximately 18x (based on recurring EPS of $4) is below Nestlé's 22x and Unilever's 20x, reflecting investor skepticism about sustained margin improvement. Demonstrating consistent ROIC above 10% could narrow this valuation gap. Revenue by segment in FY2024 showed EDP at $14.7 billion (-6.0% reported, +3.8% LFL), Specialized Nutrition at $9.7 billion (+5.1% reported, +4.6% LFL), and Waters at $5.4 billion (+3.8% reported, +5.1% LFL). The EDP reported decline masked strong underlying growth: the -6.0% reported figure included -4.8% scope (Russia exit, US divestitures) and -2.8% currency, partially offset by +3.8% like-for-like. The Waters segment's +3.8% reported growth and +5.1% LFL growth reflected strong performance in China (Mizone), Europe (Evian, Volvic), and Latin America (Bonafont). Specialized Nutrition's +5.1% reported growth was the only segment with reported growth exceeding LFL growth, reflecting favorable currency effects in China and the Rest of World. Geographic revenue distribution was Europe $10.4 billion (35% of total, +2.0% reported, +1.7% LFL), North America $7.2 billion (24%, -4.5% reported, +5.2% LFL), China/North Asia/Oceania $4.0 billion (13%, +5.7% reported, +8.0% LFL), Latin America $3.3 billion (11%, +8.4% reported, +4.2% LFL), and Rest of World $4.9 billion (16%, -10.9% reported, +5.7% LFL). The North America divergence—reported decline of 4.5% despite 5.2% LFL growth—was the most extreme, reflecting both currency headwinds (euro appreciation against the US dollar) and the Horizon Organic/Wallaby divestitures. The China/North Asia/Oceania region was the growth engine, with 8.0% LFL growth driven by infant formula market share gains, Mizone expansion, and Japanese yogurt innovation. The Q4 2024 acceleration—total company sales of $7.3 billion with +4.7% LFL growth and +4.2% volume/mix—suggested momentum heading into FY2025. This was the sixth consecutive quarter of positive volume/mix, validating de Saint-Affrique's strategy of reinvesting productivity gains into brand-building and innovation. Management guided for FY2025 like-for-like sales growth of 3-5% with recurring operating income growing faster than sales, implying margin expansion of at least 20-40 basis points. This guidance was cautiously received by analysts, who noted the challenging comparable base (Q1 2024 had +4.9% LFL growth) and persistent European weakness.